Madrigal Pharmaceuticals Inc (MDGL)

[DMOST]

Breakfast Technical Briefing on Mirati Therapeutics and Three Other Additional Biotech Stocks

ACCESSWIRE•July 17, 2018

Stock Research Monitor: KTOV, LOXO, and MDGL

LONDON, UK / ACCESSWIRE / July 17, 2018/ If you want a free Stock Review on MRTX sign up now at www.wallstequities.com/registration. Today, WallStEquities.com presents for assessment Kitov Pharma Ltd (NASDAQ: KTOV), Loxo Oncology Inc. (NASDAQ: LOXO), Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL), and Mirati Therapeutics Inc. (NASDAQ: MRTX). These stocks are part of the Biotechnology sector, which harnesses biological processes to create technologies and products for a wide variety of challenges - from expanding crop sizes to treating disease. All you have to do is sign up today for this free limited time offer by clicking the link below

Madrigal Pharmaceuticals

West Conshohocken, Pennsylvania headquartered Madrigal Pharmaceuticals Inc.’s stock finished the day 2.94% lower at $288.02 with a total trading volume of 118,219 shares. Shares of the Company have skyrocketed 149.48% in the previous three months and 1,767.83% over the past year. The stock is trading above its 50-day and 200-day moving averages by 27.56% and 129.01%, respectively. Additionally, shares of Madrigal Pharma, which focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases, have an RSI of 58.11.
https://finance.yahoo.com/news/breakfast-technical-briefing-mirati-therapeutics-113500105.html

On June 28th, 2018, research firm Raymond James initiated a 'Market Perform' rating on the Company's stock. Register for your free research report on MDGL at:

www.wallstequities.com/registration/?symbol=MDGL

GO MDGL

"PEACE"